Early sST2 Liberation after Implantation of a Left Ventricular Assist Device in Patients with Advanced Heart Failure
Background. The use of left ventricular assist device (LVAD) has increased considerably over the past decade; however, there is limited literature to assist in patient selection and monitoring. The frequency of adverse events remains high. We examined the early expression of circulating soluble ST2...
Saved in:
Main Authors: | Philipp Opfermann, Elisabeth Simader, Alessia Felli, Michele Bevilacqua, Caroline Holaubek, Martin Dworschak, Mohamed Mouhieddine, Daniel Zimpfer, Jan Hendrik Ankersmit, Barbara Steinlechner |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/5826176 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction
by: Maëlle Plawecki, et al.
Published: (2018-01-01) -
Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
by: Shan Huang, et al.
Published: (2025-01-01) -
Value of C-Reactive Protein in Predicting Left Ventricular Remodelling in Patients with a First ST-Segment Elevation Myocardial Infarction
by: Iwona Swiatkiewicz, et al.
Published: (2012-01-01) -
Focal Left Atrial Tachycardia in a Patient with Left Ventricular Noncompaction
by: Shailendra Singh, et al.
Published: (2013-01-01) -
Transcatheter edge‐to‐edge tricuspid repair for recurrence of valvular regurgitation after left ventricular assist device and tricuspid ring implantation
by: Martin Andreas, et al.
Published: (2020-06-01)